Financial Expectations for 2025
All line items are according to GAAP, except as otherwise noted.
| In millions | 2025 Expectations | |
| Total Revenues | $1,340 – $1,430 | |
| VIVITROL Net Sales | $440 – $460 | |
| ARISTADAi Net Sales | $335 – $355 | |
| LYBALVI Net Sales | $320 – $340 | |
| Cost of Goods Sold | $185 – $205 | |
| R&D Expenses | $305 – $335 | |
| SG&A Expenses | $655 – $685 | |
| GAAP Net Income a | $175 – $205 | |
| EBITDA | $215 – $245 | |
| Adjusted EBITDA | $310 – $340 | |
| Effective Tax Rate | ~17% |
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。